Fortress Biotech, Inc. (FBIO)
NASDAQ·Healthcare·Biotechnology
$2.24
-1.32%
Mkt Cap $104.64M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | $26.17M | $16.08M | -38.55% | $0.42 | -$0.21 | -150.00% | — | — |
| Q4 2025 Nov 14, 2025 | $21.02M | $17.63M | -16.12% | -$0.43 | $0.11 | +125.58% | — | — |
| Q3 2025 Aug 14, 2025 | $21.02M | $16.41M | -21.91% | -$0.31 | -$0.46 | -48.39% | — | — |
| Q2 2025 May 21, 2025 | $11.62M | $13.14M | +13.07% | -$0.44 | -$1.03 | -134.09% | — | — |
| Q1 2025 Mar 27, 2025 | $16.30M | $15.12M | -7.22% | -$0.79 | -$0.53 | +32.91% | — | — |
| Q4 2024 Nov 14, 2024 | $15.58M | $14.63M | -6.08% | -$0.27 | -$0.76 | -181.48% | — | — |
| Q3 2024 Aug 13, 2024 | $14.77M | $14.90M | +0.85% | -$1.32 | -$0.73 | +44.70% | — | — |
| Q2 2024 May 15, 2024 | $14.13M | $13.03M | -7.78% | -$2.03 | -$1.03 | +49.26% | — | — |
| Q1 2024 Mar 28, 2024 | $14.89M | $19.95M | +33.96% | -$1.97 | -$0.53 | +73.10% | — | — |
| Q4 2023 Nov 14, 2023 | $15.95M | $34.75M | +117.88% | -$3.53 | -$0.94 | +73.37% | — | — |
| Q3 2023 Aug 14, 2023 | $17.46M | $17.39M | -0.42% | -$3.90 | -$3.60 | +7.69% | — | — |
| Q2 2023 May 15, 2023 | $20.27M | $12.43M | -38.68% | -$2.85 | -$3.15 | -10.53% | — | — |
| Q1 2023 Mar 30, 2023 | $22.05M | $16.40M | -25.61% | -$3.30 | -$4.50 | -36.36% | — | — |
| Q4 2022 Nov 14, 2022 | $20.84M | $16.53M | -20.68% | -$4.05 | -$3.75 | +7.41% | — | — |
| Q3 2022 Aug 11, 2022 | $22.77M | $18.89M | -17.08% | -$3.00 | -$3.60 | -20.00% | — | — |
| Q2 2022 May 12, 2022 | $20.07M | $23.93M | +19.22% | -$4.20 | -$2.70 | +35.71% | — | — |
| Q1 2022 Mar 28, 2022 | $39.64M | $18.28M | -53.90% | $1.50 | -$5.70 | -480.00% | — | — |
| Q4 2021 Nov 15, 2021 | $19.57M | $21.09M | +7.74% | -$1.20 | -$3.90 | -225.00% | — | — |
| Q3 2021 Aug 16, 2021 | $18.42M | $17.84M | -3.13% | -$2.10 | -$0.60 | +71.43% | — | — |
| Q2 2021 May 16, 2021 | $11.59M | $11.59M | +0.00% | -$2.55 | -$1.65 | +35.29% | — | — |